AB0017 HOW DO B CELLS EVADE RITUXIMAB THERAPY IN AUTOIMMUNITY; IS IT TIME TO TARGET THE CD19+CD20- B CELLS? (2023)
Attributed to:
Modulating Metabolic Programming of Memory B cell Activation to Restore B-cell Homeostasis in Autoimmune Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2023-eular.2442
Publication URI: http://dx.doi.org/10.1136/annrheumdis-2023-eular.2442
Type: Conference/Paper/Proceeding/Abstract